Cailin Conner

DocwireNews

The burden of gout is increasing globally. The common form of inflammatory arthritis has been linked with several comorbidities, such as chronic kidney disease, cardiovascular disease, diabetes, depression, and sleep apnea. Gout is more likely to occur in men, and the risk of gout significantly increases with age.Metabolic syndrome, a cluster of conditions that occur together, includes conditions such as increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. These conditions combined significantly increase an individual&rsquo;s risk of heart disease, stroke, and type 2 diabetes. The management of metabolic syndrome have been emphasized in the prevention of cardiovascular disease. Furthermore, prior studies have demonstrated that changes in metabolic syndrome status can alter the risk of atrial fibrillation and end-stage renal disease.Prior to a study published in <a href="https://onlinelibrary.wiley.com/doi/10.1002/art.42381" target="_blank" rel="noopener">Arthritis &amp; Rheumatology</a>, the question of whether a change in metabolic status can alter the risk of gout had not been answered. In a recent large nationwide population-based cohort study, nearly 1.3 million men aged 20 to 39 years underwent three health check-ups at 2-year intervals. The primary outcome measurement was incident gout. Researchers used Cox proportional hazard models to analyze the associations between metabolic syndrome changes and incident gout.Over the duration of the study period, 18,473 men were diagnosed with gout, and the incidence rate of gout was 3.36 per 1000 person-years. Patients who had metabolic syndrome at all three checkups had near four times higher risk of incident gout compared with patients who were did not have metabolic syndrome. In addition, patients who developed metabolic syndrome over the study period had nearly double the risk of incident gout.Researchers also found that two components of metabolic syndrome, elevated triglycerides and abdominal obesity, had the greatest association with altered risk of incident gout. Patients who had metabolic syndrome but recovered had a reduced incidence of gout.In a press release published online in <a href="https://newsroom.wiley.com/press-releases/press-release-details/2022/Is-metabolic-syndrome-a-modifiable-risk-factor-for-gout/default.aspx" target="_blank" rel="noopener">Wiley</a>, Jaejoon Lee, MD, PhD, of the Sungkyunkwan University School of Medicine in South Korea, remarked &ldquo;This is the first large-scale study to explore the association between dynamic changes in metabolic syndrome and risk of gout. Prevention and recovery from metabolic syndrome can significantly lower the risk of gout in young adults.&rdquo;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Development of Metabolic Syndrome More Than Doubles the Risk of Gout

Nephrology Times

The burden of gout is increasing globally. The common form of inflammatory arthritis has been linked with several comorbidities, such as chronic kidney disease, cardiovascular ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe